Predictors of achieving HbA1c

Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes

(2014) M. Velojic-Golubovic et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of

(2011) D. Giugliano et al.   DIABETES CARE

Proportion of patients at HbA1c target

(2011) K. Esposito et al.   DIABETES OBESITY & METABOLISM

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs

(2011) Carrie Fidler et al.   JOURNAL OF MEDICAL ECONOMICS

Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project

(2010) A. J. Karter et al.   DIABETES CARE

Standards of Medical Care in Diabetes--2011

(2010)   DIABETES CARE

Relationship of baseline HbA1cand efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials

(2010) R. A. DeFronzo et al.   DIABETIC MEDICINE

Determinants of Severe Hypoglycemia Complicating Type 2 Diabetes: The Fremantle Diabetes Study

(2010) Timothy M. E. Davis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Addressing barriers to initiation of insulin in patients with type 2 diabetes

(2010) Mark Peyrot et al.   Primary Care Diabetes

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

(2009) Jaime A. Davidson et al.   CLINICAL THERAPEUTICS

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

(2009) Krzysztof Strojek et al.   CURRENT MEDICAL RESEARCH AND OPINION

Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference

(2009) Min Yang et al.   CURRENT MEDICAL RESEARCH AND OPINION

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?

(2009) I. Lingvay et al.   DIABETES CARE

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

(2009) S. Shah et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix®30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™observational study

(2009) J. Gumprecht et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

(2008) A. Liebl et al.   DIABETES OBESITY & METABOLISM

Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin Analogs and Insulin Pens

(2008) Stephen Brunton   Diabetes Technology & Therapeutics

The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

(2008) P. Valensi et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification

(2008) Julie A. Schmittdiel et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE